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(SCC) because of its low occurrence. Traditionally, obser-
vation has been recommended for patients with maxillary 
SCC and cN0 based on the low risk of cervical metastasis of 
maxillary SCC. However, several recent retrospective studies 
have reported that maxillary SCC shows aggressive regional 
(cervical) metastatic behavior and that risk of occult cervical 
metastasis is higher than previously supposed5-8. In this study, 
the authors conducted a retrospective analysis of patients 
with maxillary SCC to define the risk of occult cervical me-
tastasis and the therapeutic value of END for survival of cN0 
patients. This study aimed to give recommendations for cN0 
neck management based on this analysis.
II. Materials and Methods
This study followed the Declaration of Helsinki on medical 
protocol and ethics, and was approved by the regional Ethi-
cal Review Board of the Yonsei Dental Hospital Institutional 
Review Board (IRB No. 2-2014-0032).
Medical records of patients with maxillary SCC at the De-
partment of Oral and Maxillofacial Surgery, Yonsei Univer-
sity Dental Hospital between 1993 and 2011 were screened. 
I. Introduction
Cervical lymph node metastasis is an important prognostic 
factor for head and neck cancer patients1-4. Neck management 
for patients with evidence of cervical lymph node metastasis 
includes consensus-neck dissection and/or neck irradiation. 
Elective neck dissection (END) for patients with clinically 
negative neck nodes (cN0), however, remains controversial. 
There has been no prospective study of the risk of occult 
cervical metastasis of maxillary squamous cell carcinoma 
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currence was evident clinically and radiographically, salvage 
surgery and/or concurrent chemoradiotherapy was done. 
3. Statistical analyses
The data between groups were compared by a Mann-Whit-
ney test for continuous variables and a Fisher’s exact test for 
categorical variables. Survival curves were generated using 
the Kaplan-Meier method and differences between survival 
curves were compared by the log-rank test. Statistics were 
considered significant if P<0.05. All statistical analyses were 
performed with PASW Statistics 18.0 (IBM Co., Armonk, 
NY, USA).
III. Results
1. Patient characteristics
Of 67 patients satisfying the criteria, 23 were female and 
44 were male; mean age was 60.2 years (range, 34-83 years). 
The mean observation period was 74.8 months (range, 0-216 
months). Of 67 patients, 9 patients (13.4%) underwent END 
simultaneously with primary tumor resection (END group) 
and 58 patients (86.6%) were treated by primary tumor resec-
The primary site was categorized as maxillary gingiva or 
maxillary sinus. Maxillary gingiva indicates mucosa covering 
the alveolus and palate. A total of 124 patients with maxillary 
SCC were treated. All patients were examined by computed 
tomography (CT) and/or magnetic resonance imaging (MRI) 
to diagnose the primary tumor and cervical lymph nodes. 
Cancer staging based on the American Joint Committee on 
Cancer 7th edition TNM staging system9 was conducted. 
Maxillary sinus SCC and gingival SCC were classified dif-
ferently according to the TNM staging system. Among them, 
27 patients diagnosed with clinically positive neck node (cN+) 
were excluded. Of 97 patients diagnosed as cN0 neck, cases 
including any one of the following criteria were excluded (1) 
patients who had had radiotherapy or chemotherapy before 
surgery, (2) patients who were not treated surgically, and (3) 
patients with distant metastasis at initial assessment. Ulti-
mately, 67 patients satisfied the criteria, including 35 patients 
with maxillary gingiva and 32 patients with maxillary sinus. 
All patients underwent surgical resection of their primary 
tumor. The surgeries were performed by 3 oral and maxillo-
facial surgeons. Each surgeon made the decision on whether 
END was performed based on tumor site, tumor size, and 
patient general condition. When conducting END, selective 
neck dissection with level I-III or modified radical neck dis-
section on the ipsilateral neck was performed.
1. Occult cervical metastasis
The following are definitions of occult cervical metastasis: 
(1) Pathologically confirmed positive lymph node after 
END for cN0 neck.
(2) Regional or locoregional recurrence of untreated cN0 
neck.
(3) Regional or locoregional recurrence outside the dis-
sected levels in END patients.
In this study, the authors modified the definitions by Poe-
schl et al.5, who considered only regional recurrence (not 
locoregional) as occult cervical metastasis. However, the 
authors added locoregional recurrence to the definitions be-
cause regional recurrence could occur independently of local 
recurrence.
2. Follow-up and treatment for recurrence
After surgery, patients were followed-up every 3-6 months. 
MRI or positron emission tomography-CT was used rou-
tinely to detect the failure of primary site and neck. When re-
Table 1. Study population characteristics
 Characteristic
Non-END 
group
END group P-value
Patients
Age (yr)
Observation period (mo)
Sex
   Female
   Male
Site of primary lesion
   Gingiva
   Maxillary sinus
T stage
   1
   2
   3
   4
Histological grade
   Well
   Moderate
   Poorly
   Missing
Resection margin
   Negative
   Positive
58 (86.6)
59.7 (34-83)
78.2 (4-201)
 
19 (32.8)
39 (67.2)
 
28 (48.3)
30 (51.7)
 
10 (17.2)
10 (17.2)
15 (25.9)
23 (39.7)
 
8 (13.58)
34 (58.6)
14 (24.1)
2 (3.4)
 
41 (70.7)
17 (29.3)
9 (13.4)
62.9 (43-74)
52.6 (0-216)
 
4 (44.4)
5 (55.6)
 
7 (77.8)
2 (22.2)
 
1 (11.1)
2 (22.2)
1 (11.1)
5 (55.6)
 
2 (22.2)
5 (55.6)
2 (22.2)
-
 
7 (77.8)
2 (22.2)
 
0.265
0.110
 
0.481
 
 
0.153
 
 
0.728
 
 
 
 
0.777
 
 
 
 
>0.99
 
(END: elective neck dissection)
Values are presented as number (%) or mean (range).
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factors that predicted high risk for occult cervical metastasis.
(Table 3) No factors were identified as statistically signifi-
cant predictors of occult cervical metastasis. There was no 
relationship between advanced T stage and occult cervical 
metastasis. Neither high histological grade nor bone invasion 
were associated with incidence of occult cervical metastasis.
4. Results of salvage therapy and overall survival
Among the 7 patients who had regional recurrence, 5 pa-
tients (71.4%) were treated successfully.(Table 2) However, 
among the 12 patients with local recurrence, treatment for 
recurrence was successful for only 4 patients (33.3%). Two 
patients with locoregional recurrence died of uncontrolled 
disease, so the success rate of recurrence treatment was 0%. 
Unsurprisingly, all the patients with distant metastases died 
from cancer. Five-year overall survival rate was 74.0% for 
the non-END group and 51.9% for the END group. The non-
END group survival rate was higher than the END group, but 
the difference was not statistically significant (P=0.241).(Fig. 
1) 
tion (non-END group).(Table 1) The primary tumor site was 
maxillary gingiva in 35 patients and maxillary sinus in 32 
patients. The rate of maxillary gingiva to maxillary sinus was 
higher in the END than in the non-END group (77.8% and 
48.3%, respectively; P>0.05). That meant there was a ten-
dency to conduct END for a maxillary gingiva primary site, 
but the difference was not statistically significant. In addition, 
there was a slight tendency to conduct END for T4 staged 
tumors (39.7% of non-END group, 55.6% of END group; 
P>0.05). The distribution of histological grade and clearance 
of tumor resection margin was similar between the 2 groups.
2. Incidence of occult cervical metastasis
Table 2 summarizes the patterns of recurrence after prima-
ry surgery according to the modality of neck management. Of 
the 9 patients who underwent END, positive lymph node was 
confirmed pathologically in one patient. During the follow-
up period, one patient in the END group whose neck had 
been confirmed pathologically negative had locoregional re-
currence outside the dissected levels. In the non-END group, 
locoregional recurrence was detected in one patient and re-
gional recurrence was detected in 7 patients at 12 months on 
average (range, 1-47 months) after primary surgery. There-
fore, 10 of 67 patients had occult cervical metastasis with an 
incidence of 14.9%. Incidence of occult cervical metastasis 
for SCC in maxillary gingiva patients was higher than in 
maxillary sinus patients, being 17.1% (6 of 35 patients) and 
12.5% (4 of 32 patients), respectively.
3. Predisposing factors for occult cervical metastasis
Several factors such as age, sex, site of primary lesion, mo-
dality of neck management, T stage, histological grade, re-
section margin, and bone invasion were analyzed to identify 
Table 2. The patterns of recurrence and results of recurrence 
treatment
Site of 
recurrence
Non-END group 
(n=58)
END group  
(n=9)
Success rate 
of recurrence 
treatment
Local
Locoregional
Regional
Distant
11
1
7
0
1
1
0
3
4/12 (33.3)
0/2 (0)
5/7 (71.4)
0/3 (0)
(END: elective neck dissection)
Values are presented as number only or number (%).
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Table 3. Analysis of the predisposing factors for occult metastasis
Variable No. of patients (%) P-value
Patients 
Age1
   ≤61 yr
   >62 yr
Sex
   Female
   Male
Neck management
   Observation
   END
T stage
   Early (1, 2)
   Advanced (3, 4)
Histological grade
   Well
   Moderate
   Poorly
   Missing
Resection margin
   Negative
   Positive
Bone invasion
   Negative
   Positive
10/67 (14.9)
 
5/34 (14.7)
5/33 (15.2)
 
1/23 (4.3)
9/44 (20.5)
 
8/58 (13.8)
2/9 (22.2)
 
3/23 (13.0)
7/44 (15.9)
 
1/10 (10.0)
6/39 (15.4)
2/16 (12.5)
2
 
7/48 (14.6)
3/19 (15.8)
 
3/23 (13.0)
7/44 (15.9)
 
 
>0.99
 
 
0.146
 
 
0.614
 
 
>0.99
 
 
>0.99
 
 
 
 
>0.99
 
 
>0.99
 
(END: elective neck dissection)
161 years is the median age of the subjects.
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that tumor extension to the nasopharynx or oral cavity was 
a significant factor for neck node metastasis13. In the present 
study, T stage, histological grade, and bone invasion of the 
primary tumor were not significant predisposing factors for 
occult cervical metastasis.
Most studies have focused on the incidence of neck metas-
tasis to prove the necessity for END. The authors believe that 
the impact of END on patient survival rate should also be 
considered. A search yielded no study which demonstrated 
an impact of END on survival rate in SCC of the maxillary 
sinus. In SCC of the maxillary gingiva, two studies reported 
a higher 5-year overall survival rate for the END group than 
for the non-END group, but the differences were not statisti-
cally significant5,6. They also noted that END seemed to con-
fer a survival benefit in advanced T stages. In contrast with 
their results, the 5-year overall survival rate in this analysis 
was higher for the non-END than the END group. Small 
sample size and selection bias (i.e., predilection of END for 
advanced T stages) may partly account for the results, but 
the most important factor was the high success rate of treat-
ment for regional recurrence in the non-END group. Many 
studies reported a low success rate of treatment for regional 
recurrence, which was one of the reasons for recommend-
ing END5,16-18,23,24. In this study, however, the success rate 
of treatment for regional recurrence was high (71.4%), in 
contrast with low success rates of local or locoregional recur-
rence (33.3% and 0%, respectively). Hence, local control of 
the primary tumor is more important than modality of neck 
management for survival of cN0 patients. With complete lo-
cal control, observation of cN0 neck is recommended when 
early detection of regional recurrence is possible. Feng et 
al.6 also reported that early detection could lead to a 100% 
success rate of cervical salvage irrespective of T stage. The 
authors believe the key factor in early detection of regional 
recurrence is patient education with periodic follow-up. In 
our hospital, in addition to periodic follow-up, patients are 
instructed about signs of local recurrence such as unhealed 
ulceration over 2 weeks, swelling, or easy bleeding at the 
site, and signs of regional recurrence such as a palpable mass 
in the neck. They are encouraged to come to the hospital as 
soon as possible to be examined and screened for recurrence 
if they feel any abnormalities. 
This study has the limitations of small sample size, ob-
servation period range and surgeon bias for selection of 
END, such as predilection of END for advanced T stages. A 
properly-designed study with a larger sample size is needed 
to confirm the therapeutic value of END in survival of cN0 
IV. Discussion
Considering morbidity and benefits of neck dissection, 
END is recommended for patients whose risk of occult cervi-
cal metastasis is greater than 15% to 20%1,10. In the majority 
of recent studies, the risk of occult cervical metastasis of 
SCC in the maxillary gingiva was reported to be greater than 
20%5,6,11,12. On the other hand, cervical lymph node metasta-
sis of SCC in the maxillary sinus is reported to be less than 
15%7,13-15. The maxillary sinus is usually considered distinct 
from the maxillary gingiva when it comes to cancer, but their 
proximity frequently obscures tumor origin, especially in ad-
vanced stages. In this study, the authors defined the primary 
site of maxillary SCC as maxillary gingiva or maxillary sinus 
considering anatomical proximity and lymphatic drainages. 
Risk of occult cervical metastasis of maxillary SCC in the 
present study was 14.9%. Consistent with other studies, the 
incidence of maxillary gingiva was higher than that of maxil-
lary sinus (17.1% vs 12.5%, respectively), although slightly 
less so than in other studies. This incidence is not high 
enough to recommend END in cN0 patients.
Many studies reported a correlation between advanced 
maxillary SCC T stage and lymph node metastasis5,6,8,16-20. 
In accordance with their results, Ogura et al.21 reported that 
radiographical evidence of bone invasion was an indicator of 
cervical metastasis in SCC of the maxillary gingiva. How-
ever, another study of maxillary sinus SCC demonstrated that 
T1 and T2 stages showed significantly more cervical metas-
tases than T3 and T4 stages and that involvement of other 
structures was no predictor of cervical metastasis22. Another 
study also reported T stage was not a significant factor, but 
Fig. 1. Kaplan-Meier survival curves of overall survival for non-
END group versus END group. (END: elective neck dissection)
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patients.
V. Conclusion
The incidence of occult cervical metastasis of maxillary 
SCC is not high enough to recommend END. For survival 
of cN0 patients, local control of the primary tumor is more 
important than modality of neck management. When early 
detection of regional recurrence is possible, observation of 
cN0 neck is the treatment of choice irrespective of the site or 
T stage of maxillary SCC. Because the key enabler of early 
detection is patient education with periodic follow-up, the 
patients should be instructed about signs of recurrence and 
encouraged to come to the hospital as soon as possible if they 
feel any abnormalities.
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